Company intelligence / Profile preview
Duchesnay
Blainville, Quebec, Canadaduchesnay.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Duchesnay has a long-standing focus on women’s health, offering approved therapies for conditions such as nausea and vomiting of pregnancy and menopausal symptoms. Its lead products are commercialized in over 40 countries. The company’s combination therapy for morning sickness has a strong safety record spanning four decades. Recent regulatory approvals have expanded its reach globally.
- Therapeutic areas
- Women's HealthUrology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Strategic alliances in over fifty countries; specific partners not named but includes global distribution partners.
Beyond the preview
Go deeper on Duchesnay.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Duchesnay.